Manulife (Manufacturers Life Insurance)
DNLI icon

Manulife (Manufacturers Life Insurance)’s Denali Therapeutics DNLI Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Sell
117,348
-8,094
-6% -$166K ﹤0.01% 1407
2026
Q1 		$2.41M Sell
125,442
-58,796
-32% -$1.17M ﹤0.01% 1427
2025
Q4 		$3.03M Sell
184,238
-21,607
-10% -$365K ﹤0.01% 1367
2025
Q3 		$2.99M Sell
205,845
-109,257
-35% -$1.57M ﹤0.01% 1374
2025
Q2 		$4.41M Buy
315,102
+56,970
+22% +$802K ﹤0.01% 1221
2025
Q1 		$3.51M Buy
258,132
+49,611
+24% +$951K ﹤0.01% 1296
2024
Q4 		$4.25M Buy
208,521
+1,702
+0.8% +$43.6K ﹤0.01% 1272
2024
Q3 		$6.02M Buy
206,819
+34,538
+20% +$856K 0.01% 1128
2024
Q2 		$4M Buy
172,281
+23,165
+16% +$445K ﹤0.01% 1258
2024
Q1 		$3.06M Buy
149,116
+47,893
+47% +$900K ﹤0.01% 1363
2023
Q4 		$2.17M Sell
101,223
-12,175
-11% -$241K ﹤0.01% 1444
2023
Q3 		$2.34M Sell
113,398
-5,551
-5% -$141K ﹤0.01% 1389
2023
Q2 		$3.51M Buy
118,949
+3,766
+3% +$106K ﹤0.01% 1235
2023
Q1 		$2.65M Buy
115,183
+3,124
+3% +$86K ﹤0.01% 1324
2022
Q4 		$3.14M Buy
112,059
+1,802
+2% +$53.6K ﹤0.01% 1261
2022
Q3 		$3.29M Sell
110,257
-10,030
-8% -$326K ﹤0.01% 1236
2022
Q2 		$3.5M Buy
120,287
+2,202
+2% +$57.7K ﹤0.01% 1256
2022
Q1 		$3.82M Buy
118,085
+71,589
+154% +$2.46M ﹤0.01% 1313
2021
Q4 		$2.09M Sell
46,496
-439
-0.9% -$20.8K ﹤0.01% 1481
2021
Q3 		$2.37M Sell
46,935
-4,398
-9% -$248K ﹤0.01% 1457
2021
Q2 		$4.03M Buy
51,333
+15,287
+42% +$946K ﹤0.01% 1372
2021
Q1 		$2.06M Sell
36,046
-2,218
-6% -$148K ﹤0.01% 1528
2020
Q4 		$3.21M Buy
38,264
+1,117
+3% +$67.5K ﹤0.01% 1387
2020
Q3 		$1.33M Sell
37,147
-1,051
-3% -$31.7K ﹤0.01% 1552
2020
Q2 		$905K Buy
38,198
+4,727
+14% +$111K ﹤0.01% 1664
2020
Q1 		$586K Buy
33,471
+3,027
+10% +$63.1K ﹤0.01% 1753
2019
Q4 		$530K Sell
30,444
-839
-3% -$14K ﹤0.01% 2012
2019
Q3 		$496K Sell
31,283
-44
-0.1% -$841 ﹤0.01% 2022
2019
Q2 		$650K Buy
31,327
+249
+0.8% +$5.58K ﹤0.01% 1887
2019
Q1 		$722K Buy
31,078
+2,977
+11% +$62.3K ﹤0.01% 1874
2018
Q4 		$581K Sell
28,101
-3,042
-10% -$55.2K ﹤0.01% 1882
2018
Q3 		$677K Buy
31,143
+15,499
+99% +$256K ﹤0.01% 2069
2018
Q2 		$238K Buy
15,644
+1,179
+8% +$22.2K ﹤0.01% 2988
2018
Q1 		$285K Buy
+14,465
New +$297K ﹤0.01% 2746

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s DNLI Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Denali Therapeutics (DNLI) stake by 6.5% in Q2 2026, selling an estimated $166K and leaving 117,348 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Manulife (Manufacturers Life Insurance) first reported a position in DNLI in Q1 2018 and has held it in 34 quarters since. The position peaked at $6.02M in Q3 2024. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 117,348 shares of Denali Therapeutics worth $3.02M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 8,094 Denali Therapeutics shares in Q2 2026, an estimated $166K.
  • Denali Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1407 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Denali Therapeutics in Q1 2018 and has held it in 34 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Denali Therapeutics position peaked at $6.02M in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.